about
Optimal management of pernicious anemiaThe role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapiesAntiplatelet therapy in acute coronary syndromes: focus on ticagrelorReducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectivesUpdate and new approaches in the treatment of Castleman diseasePotential role of a new PEGylated recombinant factor VIII for hemophilia A.Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopeniaStrategies to encourage physical activity in patients with hemophilia to improve quality of lifeMidostaurin: an emerging treatment for acute myeloid leukemia patientsCritical appraisal of eculizumab for atypical hemolytic uremic syndromeNew developments in the management of moderate-to-severe hemophilia BPanobinostat for the treatment of multiple myeloma: the evidence to dateEmerging and future therapies for hemophiliaTranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidenceGlanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment optionsCritical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolismHematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerationsHemophagocytic lymphohistiocytosis: review of etiologies and managementContribution of blood platelets to vascular pathology in Alzheimer's diseaseClinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation - patient considerationsHematopoietic stem and progenitor cell harvesting: technical advances and clinical utilityCatridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?IDH1 and IDH2 mutations as novel therapeutic targets: current perspectivesAnimal models of β-hemoglobinopathies: utility and limitationsHematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatmentTherapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia AAcquired hypofibrinogenemia: current perspectivesOnce-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia BRuxolitinib in the treatment of polycythemia vera: patient selection and special considerationsBody surface area: a predictor of response to red blood cell transfusionSolitary plasmacytoma of the jawSubclinical leukopenia in a cross section of Nigerian blood donorsThe wandering spleen: an unusual case of thrombocytopeniaUpdate on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IIRomiplostim as a treatment for immune thrombocytopenia: a review.Prevalence of HIV-related thrombocytopenia among clients at Mbarara Regional Referral Hospital, Mbarara, southwestern UgandaClinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA testPrevalence of thrombocytopenia among pregnant women attending antenatal care service at Gondar University Teaching Hospital in 2014, northwest EthiopiaPublic banking of umbilical cord blood or storage in a private bank: testing social and ethical policy in northeastern Italy.Back pain: the sole of presentation of sickle cell disease.
P1433
Q24601153-03FCFC35-F0D9-42FF-9F78-B7421D4D33B7Q24605471-3AB16AA7-12FD-44C3-A0ED-8B5D772341E3Q24605508-6FFCADE2-4B49-43C6-9DE3-71653B31D151Q26740347-688F6AA0-DA9C-4DF9-9DA8-F2D8E52562C3Q26740703-0BE7CF04-B56A-4AA9-941C-5156D3D0D3ABQ26744309-36F2331F-1671-4D1D-A4DB-5C66ADD6962CQ26745753-AACED052-A2FE-4D7A-9018-AE405459F168Q26747690-8216FA64-A159-4A7A-9F84-9F964CDADB08Q26749271-BB661D8F-18F8-4ADB-8D51-79381D71993CQ26750692-A7F79A5F-7966-4DB8-AFC9-0C98CDE639B2Q26751323-854BDE48-C037-4ACF-856A-E90510F6A00DQ26778674-C6157376-FBA1-4C07-8A6E-07FABC8BF42EQ26781143-F88787F5-C584-4729-810C-523672E7E0F3Q26783461-68C74EDC-6AAE-40A5-9E66-4DFE87CF74B8Q26799688-EEB24B78-2CE9-45BF-8E03-5617C0B6D15AQ26799691-D719510B-42C4-411B-90F5-BC4A67E4D1C6Q26800236-594FFB68-6A9A-4797-8B7D-C67A66E3A713Q26830538-84121DA5-3CE5-4B89-B8B3-78130E2A9E57Q26861509-520ADA81-19F1-4F46-89CD-63F9D3AFDCB4Q27000967-B9A097E6-F265-4A9E-B332-3C39713F8DA2Q27012881-EE69D6C3-8966-4D18-B2A0-212C063118B7Q27026565-DAD92E07-4521-481E-8DD5-8FAB2C927E08Q28066926-147A9B0D-D382-456F-B47D-819AD328B7C7Q28067142-744F8CA5-AC56-408D-AFBF-FB2BE155BB26Q28069228-C45D6BEA-A187-4C85-9DE1-61A48B46173CQ28075081-63D64E7A-F4F8-4769-B157-CACB3E5F1250Q28077374-23721C04-56D1-4571-8BC0-54AF20FF9E0BQ28078281-6B6F0878-360A-41D4-AFFD-AA2A4097B2E0Q28078404-0978F980-97FA-4605-9755-9955855E889AQ30356163-E2EFB82B-DCA5-4040-B72D-619EF29BCB87Q33399368-4E3A8391-25E8-49CE-BA9E-5721D66819A0Q33399385-C8F8E67B-EE68-4FA1-BA40-3C5D1A14697DQ33399387-6E4B1A68-63CC-4658-95B4-0DAE699310B4Q33417258-E2FCB752-C683-4761-8AC4-3D1D6C2A8D75Q33420059-33D6B2B3-1F42-4727-8465-45D6E649C84BQ33422442-1364FFBA-A098-4E6F-9133-34A491C76549Q33428198-D23BADF2-DF00-46FF-8973-292845248C6AQ33443220-336D355B-7F1F-4AB0-AA7C-484ECACA549FQ33455607-DC96BAD7-2D3C-4D06-8092-B842B6264BEDQ33610476-0645C5C3-625A-40AC-A4CC-97914D8670E9
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of Blood Medicine
@ast
Journal of Blood Medicine
@en
Journal of Blood Medicine
@es
Journal of Blood Medicine
@it
Journal of Blood Medicine
@nl
type
label
Journal of Blood Medicine
@ast
Journal of Blood Medicine
@en
Journal of Blood Medicine
@es
Journal of Blood Medicine
@it
Journal of Blood Medicine
@nl
prefLabel
Journal of Blood Medicine
@ast
Journal of Blood Medicine
@en
Journal of Blood Medicine
@es
Journal of Blood Medicine
@it
Journal of Blood Medicine
@nl
P31
P3181
P1055
P1058
P1156
21100397702
P1476
Journal of Blood Medicine
@en